(Q34385721)

1 August 2017

1 reference

title

Current treatments and emerging therapeutic approaches in male erectile dysfunction (English)

1 reference

1 August 2017

Hatzichristou DG

1

1 reference

1 August 2017

Pescatori ES

series ordinal

2

1 reference

1 August 2017

publication date

1 October 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

88 Suppl 3

1 reference

1 August 2017

page(s)

11-17

1 reference

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Contextual approaches to the physiology and classification of erectile function, erectile dysfunction, and sexual arousal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Treatment of erectile dysfunction with sildenafil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Sildenafil (Viagra) and ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Apomorphine: an update of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-4096.2001.123.X

10.1046/J.1464-4096.2001.123.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference